Evidence map›Paper›PMID 32436147›Full record

ArticleBreast cancer research and treatment2020

Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study.

Trygve Lofterød, Hanne Frydenberg, Vidar Flote, Anne Elise Eggen, Anne McTiernan, Elin S Mortensen, Lars A Akslen, Jon B Reitan, Tom Wilsgaard, Inger Thune

Open access · hybridAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Breast cancer diagnosis as a window of opportunity for smoking cessation: analysis of changes in smoking behaviour in 736 smoking breast cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Article
  8. Integrating Knowledge of Modifiable and Non-modifiable Risk Factors: A Comprehensive Framework for Breast Cancer Prevention Practices in Women.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Observational
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Prevalence and impact of metabolic associated fatty liver disease in non‑metastatic breast cancer women at initial diagnosis: a cross‑sectional study in China: a letter to the editor.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Trygve LofterødDepartment of Oncology, Oslo University Hospital, Oslo, Norway. tlofteroed@hotmail.com.ORCID http://orcid.org/0000-0002-6019-3305
Hanne FrydenbergDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Vidar FloteDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Anne Elise EggenFaculty of Health Services, Institute of Community Medicine, University of Tromsø, Tromsø, Norway.
Anne McTiernanPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
Elin S MortensenDepartment of Pathology, University Hospital of North Norway, Tromsø, Norway.
Lars A AkslenDepartment of Clinical Medicine, Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
Jon B ReitanDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Tom WilsgaardFaculty of Health Services, Institute of Community Medicine, University of Tromsø, Tromsø, Norway.
Inger ThuneDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NOUiT The Arctic University of Norway · NOFred Hutch Cancer Center · USHaukeland University Hospital · NOUniversity Hospital of North Norway · NO

Funding

Breast Cancer Research Foundation BCRF-18-107Breast Cancer Research Foundation BCRF-19-107EkstraStiftelsen Helse og Rehabilitering 2013/FOM 5628Kreftforeningen 2012/2/0054
6 · The paper itself

Abstract

purposeWhether an unfavorable lifestyle not only affects breast cancer risk, but also influences age at onset of breast cancer and survival, is under debate.

methodsIn a population-based cohort, the Energy Balance and Breast Cancer Aspects throughout life (EBBA-Life) study, a total of 17,145 women were included. During follow-up, 574 women developed invasive breast cancer. Breast cancer cases were followed for an additional 9.1 years. Detailed medical records were obtained. Cox's proportional hazard regression models were used to study the association between pre-diagnostic lifestyle factors (weight, physical activity, alcohol use, smoking, and hypertension), breast cancer risk, age at diagnosis, and survival.

resultsAt study entry, 34.3% of the participating women were overweight and 30.7% were physically inactive. Mean age at breast cancer diagnosis was 58.0 years, and 78.9% of the tumors were estrogen receptor positive. Among menopausal women who did not use hormone therapy and had an unfavorable lifestyle (3-5 unfavorable factors), compared with women who had a favorable lifestyle, we observed a twofold higher risk for postmenopausal breast cancer (hazard ratio [HR] 2.13, 95% confidence interval [CI] 1.23-3.69), and they were 3.4 years younger at diagnosis (64.8 versus 68.2 years, P = 0.032). Breast cancer patients with an unfavorable lifestyle, compared with patients with a favorable lifestyle, had almost a two times higher overall mortality risk (HR 1.96, 95% CI 1.01-3.80).

conclusionsOur study supports a healthy lifestyle improving breast cancer prevention, postponing onset of disease, and extending life expectancy among breast cancer patients.

Indexed as

Body Mass IndexLife StyleSedentary BehaviorAdultAgedAged, 80 and overAge of OnsetBreast NeoplasmsCohort StudiesFemaleFollow-Up StudiesHumansMiddle AgedNorwayPrognosisRisk FactorsBreast cancerLifestyleOnsetRiskSurvival

Identifiers

PMID32436147
PMCPMC7275030
OpenAlexW3027585888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.